OLANZAPINE PAMOATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for olanzapine pamoate and what is the scope of freedom to operate?
Olanzapine pamoate
is the generic ingredient in one branded drug marketed by Cheplapharm and is included in one NDA. Additional information is available in the individual branded drug profile pages.Two suppliers are listed for this compound.
Summary for OLANZAPINE PAMOATE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 29 |
| Clinical Trials: | 2 |
| Patent Applications: | 130 |
| What excipients (inactive ingredients) are in OLANZAPINE PAMOATE? | OLANZAPINE PAMOATE excipients list |
| DailyMed Link: | OLANZAPINE PAMOATE at DailyMed |
Recent Clinical Trials for OLANZAPINE PAMOATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Shalvata Mental Health Center | N/A |
| Eli Lilly and Company | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for OLANZAPINE PAMOATE
US Patents and Regulatory Information for OLANZAPINE PAMOATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-002 | Dec 11, 2009 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-003 | Dec 11, 2009 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-001 | Dec 11, 2009 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OLANZAPINE PAMOATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-001 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
| Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-002 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
| Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-003 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
| Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-003 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
| Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-002 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
| Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-001 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
